The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSGZ.L Regulatory News (SGZ)

  • There is currently no data for SGZ

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ISSUE OF SHARES

23 Mar 2016 09:38

RNS Number : 0244T
Scotgold Resources Ltd
23 March 2016
 

23 March 2016

 

The Company Announcements Office

Australian Securities Exchange Limited

4th Floor 20 Bridge Street

SYDNEY NSW 2000

 

 

ISSUE OF SHARES

 

Scotgold Limited (ASX: SGZ, AIM: SGZ) ("Company") advises that on 22 March 2016 it issued 73,900,000 fully paid shares to a sophisticated and private Section 708 exempt investor Mr Nat Le Roux, a Director of the Company. The shares were issued through the conversion of rights in a Convertible Note held by Mr Le Roux previously approved by shareholders on 30 July 2014.

 

Please find attached a Form 3B and Section 708A Notice in respect of this issue.

 

Following conversion, Mr Nat Le Roux's holding will be 576,120,806 ordinary shares representing 40.66% of the enlarged issued share capital and Total Voting Rights of the Company.

 

Admission of the 73,900,000 new ordinary shares is anticipated on the 30th March. Following admission, the Company's enlarged issued share capital will comprise 1,416,733,693 shares, with voting rights. The Company does not hold any Shares in treasury, therefore the total number of shares in the Company with voting rights will be 1,416,733,693.

 

 

For further information please contact:

 

Scotgold Resources

Limited

Stockdale Securities

Limited

Capital Markets

Consultants

Vicarage Capital

Limited

Richard Gray - CEO

Robert Finlay/

Alastair Stratton/ Ed Thomas

Simon Rothschild

Rupert Williams

Tel: +44 (0)1838 400 306

Tel: +44 (0)20 7601 6100

Tel +44 (0)7703 167 065

Tel: +44 (0)20 3651 2911

 

NOTICE PURSUANT TO SUBSECTION 708A(5)(E) OF THE CORPORATIONS ACT 2001 (CTH) (ACT)

 

Scotgold Limited (ASX: SGZ, AIM: SGZ) ("Company") advises that on 22 March 2016 it issued 73,900,000 fully paid shares to a sophisticated and private Section 708 exempt investor Mr Nat Le Roux, a Director of the Company. The shares were issued through conversion of rights in a Convertible Note held by Mr Le Roux previously approved by shareholders on 30 July 2014.

 

As required by subsection 708A(6) of the Act the directors of the Company advise that:

 

(i) the Company issued the shares without disclosure to investors under Part 6D.2 of the Act;

 

(ii) this Notice is being given pursuant to subsection 708A(5)(e) of the Act;

 

(iii) as at the date of this Notice, the Company has complied with:

(a) the provisions of Chapter 2M of the Act as they apply to the Company, and

 

(b) section 674 of the Act; and

 

(iv) as at the date of this Notice, the Company is not in possession of any excluded information as defined in subsections 708A(7) and 708A(8) of the Act

 

 

 

 

 

 

 

 

 

 

 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

 

 

Name of entity

SCOTGOLD RESOURCES LIMITED

 

ABN

42 127 042 773

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

Ordinary fully paid shares

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

73,900,000

3

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

 

Fully Paid Ordinary Shares issued through exercise of Convertible Note.

 

 

 

 

 

 

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Yes

 

 

5

Issue price or consideration

 

A$0.006 per share

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

 

 

 

 

 

Completion of ongoing technical studies, further exploration and working capital

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

Yes

 

 

6b

The date the security holder resolution under rule 7.1A was passed

30 Nov 2015

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

Nil

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

Nil

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

73,900,000

 

 

6f

Number of +securities issued under an exception in rule 7.2

Nil

 

 

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.

N/A

 

 

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

N/A

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

7.1 Capacity: 200,010,054

7.1A Capacity: 133,340,036

 

 

7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

22 March 2016

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)

 

 

 

1,333,400,361

Fully Paid Ordinary Shares

 

 

 

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)

 

 

 

3,000,000

Options Exercise at A$0.08 Expiry 31 March 2022

7,111,111

Options Exercise at £0.045 Expiry 28 March 2016

30,000,000

Options Exercise at £0.0069 Expiry 22 September 2017

124,095,889

Options Exercise at £0.01 Expiry 30 September 2017

56,846,154

Options Exercise at $0.012 Expiry 31 March 2016

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

No plans to pay dividends at this stage

 

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of +securities

(tick one)

 

(a)

+Securities described in Part 1

 

(b)

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 

 

Quotation agreement

 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

· The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

· There is no reason why those +securities should not be granted +quotation.

 

· An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

· Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

· If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ............................................................ Date: 22 March 2016

(Company secretary)

 

Print name: Gabriel Chiappini

== == == == ==

 

 

 

Appendix 3B - Annexure 1

 

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

 

Part 1

 

Rule 7.1 - Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

Insert number of fully paid +ordinary securities on issue 12 months before the +issue date or date of agreement to issue

1,045,392,472

Add the following:

• Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2

• Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval

• Number of partly paid +ordinary securities that became fully paid in that 12 month period

Note:

• Include only ordinary securities here - other classes of equity securities cannot be added

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

90,000,000 - 4 May 2015

95,295,889 - 7 Oct 2015

28,800,000 - 28 Oct 2015

12,000 - 20 Jan 2016

73,900,000 - 22 Mar 2016

 

 

Subtract the number of fully paid +ordinary securities cancelled during that 12 month period

Nil

"A"

1,333,400,361

 

Step 2: Calculate 15% of "A"

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

200,010,054

Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule 7.1 or rule 7.4

Note:

• This applies to equity securities, unless specifically excluded - not just ordinary securities

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

Nil

"C"

Nil

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in Step 2

200,010,054

Subtract "C"

Note: number must be same as shown in Step 3

Nil

Total ["A" x 0.15] - "C"

200,010,054

[Note: this is the remaining placement capacity under rule 7.1]

 

Part 2

 

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

"A"

Note: number must be same as shown in Step 1 of Part 1

1,333,400,361

Step 2: Calculate 10% of "A"

"D"

0.10

Note: this value cannot be changed

Multiply "A" by 0.10

133,340,036

 

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities - not just ordinary securities

• Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

Nil

"E"

Nil

 

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in Step 2

133,340,036

 

Subtract "E"

Note: number must be same as shown in Step 3

Nil

Total ["A" x 0.10] - "E"

133,340,036

Note: this is the remaining placement capacity under rule 7.1A

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOESEWSUDFMSEDD
Date   Source Headline
22nd Oct 20187:00 amRNSDirector Dealing
18th Oct 201812:36 pmRNSTR1 form
18th Oct 201812:31 pmRNSPlanning progress at Cononish
15th Oct 20185:56 pmRNSDirector/PDMR Shareholding
9th Oct 20187:00 amRNSSubscription to raise £750,000
2nd Oct 20184:29 pmRNSAmendment to Secured Loan Agreement
27th Sep 201812:48 pmRNSAnnual Report Directorship Clarification
27th Sep 201811:41 amRNSANNUAL RESULTS FOR THE YEAR ENDED 30 JUNE 2018
19th Sep 201811:13 amRNSIssue of Equity
13th Aug 20182:15 pmRNSProject Update on Cononish Gold and Silver Mine
22nd Jun 201812:59 pmRNSUpdate on sale of French Subsidiary
18th Jun 20187:00 amRNSAppointment of Directors and change of auditors
14th Jun 20181:34 pmRNSHolding(s) in Company
24th May 20189:26 amRNSHolding(s) in Company
21st May 20185:20 pmRNSHolding(s) in Company
21st May 201811:50 amRNSHolding(s) in Company
18th May 20187:00 amRNSPlacing, Subscription and Debt funding
3rd May 201811:16 amRNSGrant of Warrants to Executive Management
23rd Mar 20187:00 amRNSConversion of Options and Issue of Equity
20th Mar 20187:00 amRNSAmendment to Loan Agreement
19th Mar 20187:00 amRNSEarn In Agreement to Portuguese Subsidiary
15th Mar 20187:10 amRNSConditional Sale of French Subsidiary
13th Mar 20189:48 amRNSInterim Financial Report - REPLACEMENT
13th Mar 20187:21 amRNSInterim Financial Report
8th Mar 20187:00 amRNSAppointment of Nominated Adviser and Joint Broker
27th Feb 20185:50 pmRNSPlanning Application Granted
15th Feb 20183:40 pmRNSPlanning Application
12th Feb 201812:07 pmRNSPlanning Application
11th Jan 20181:50 pmRNSHolding(s) in Company
5th Jan 201811:41 amRNSHolding(s) in Company
4th Jan 201812:01 pmRNSCompletion of Placing
4th Jan 201811:05 amRNSDirector/PDMR Shareholding
21st Dec 20177:00 amRNSResults of Rights Issue
19th Dec 20174:40 pmRNSSecond Price Monitoring Extn
19th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20173:00 pmRNSRights Issue - Extension of Acceptance Period
30th Nov 201711:56 amRNSPLANNING APPLICATION
28th Nov 201711:19 amRNSConversion of Options and Issue of Equity
28th Nov 201710:22 amRNSResults of Annual General Meeting
13th Nov 20177:00 amRNSRights Issue
8th Nov 20173:15 pmRNSConversion of Options and Issue of Equity
7th Nov 201712:17 pmRNSNotice of Annual General Meeting
9th Oct 20177:00 amRNSDirectorate Change
4th Oct 20177:00 amRNSPresentation
2nd Oct 20174:18 pmRNSExercise of Options and Issue of Equity
29th Sep 20177:00 amRNSAnnual Results
31st Aug 20179:40 amRNSChange of Registered Office
25th Aug 201710:30 amRNSCompletion of Share Consolidation
21st Aug 201712:56 pmRNSResult of Meeting
18th Aug 201711:20 amRNSPlanning Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.